Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Research started with animal models, which established its safety to the point that human trials got started, too
Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) AOD-9604 is a modified C-terminal fragment (residues 176191, Tyr-hGH177-191) of human growth hormone, studied for lipolytic and anti-obesity properties
B12 shots ensure expectant mothers maintain optimal levels to support fetal development and reduce the risk of health issues for both mother and baby
Compounding of unknown risks: Combining two compounds with incomplete human safety data multiplies the uncertainty considerably
